サルコペニア診療ガイドライン　2017年版　一部改訂

出版社： ライフサイエンス出版
著者：
発行日： 2020-04-03
分野： 臨床医学：内科  >  老人医学
ISBN： 9784897754109
電子書籍版： 2020-04-03 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

2,420 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,694 円(税込)

購入する

商品紹介

サルコペニア診断基準が改訂。
診断基準がなぜ変わったか、どう変わったかについて改訂のポイントを解説。
超高齢社会で医療スタッフ必読のガイドライン。

目次

  • 表紙
  • 目次
  • サルコペニア診療ガイドライン一部改訂の経緯
  • サルコペニア診断基準 ( AWGS2019 ) について
  • 序文 : サルコペニア診療ガイドライン作成にあたって
  • サルコペニア診療ガイドラインについて
  • 作成委員の利益相反
  • ガイドライン作成組織
  • 略語一覧
  • 第1章 サルコペニアの定義・診断
  • CQ1 サルコペニアの定義は ?
  • CQ2 サルコペニア肥満の定義と意義は ?
  • CQ3 サルコペニア, サルコペニア肥満のスクリーニング方法・診断方法とは ?
  • 第2章 サルコペニアの疫学
  • [A] 一般集団における疫学
  • CQ1 サルコペニアの有病率は ?
  • CQ2 サルコペニアの要因, 危険因子は ?
  • CQ3 サルコペニアの予後, 転帰は ?
  • [B] 各種疾患における疫学
  • CQ1 生活習慣病 ( 非消耗性疾患 ) におけるサルコペニアの有病率は ?
  • CQ2 消耗性疾患におけるサルコペニアの有病率は ?
  • CQ3 運動器疾患におけるサルコペニアの有病率は ?
  • CQ4 神経変性疾患ならびに認知機能障害におけるサルコペニアの有病率は ?
  • CQ5 慢性疼痛, 低栄養, フレイル, 廃用症候群, ICUAWにおけるサルコペニアの有病率は ?
  • 第3章 サルコペニアの予防
  • CQ1 栄養・食事がサルコペニア発症を予防・抑制できるか ?
  • CQ2 運動がサルコペニア発症を予防・抑制できるか ?
  • CQ3 生活習慣病, 慢性疾患に対する治療がサルコペニア発症を予防・抑制できるか ?
  • 第4章 サルコペニアの治療
  • CQ1 運動療法はサルコペニアの治療法として有効か ?
  • CQ2 栄養療法はサルコペニアの治療法として有効か ?
  • CQ3 薬物療法はサルコペニアの治療法として有効か ?
  • CQ4 複数の治療法の組み合わせはサルコペニアの治療法として有効か ?
  • CQ5 二次性サルコペニアに対する介入は原疾患に有効か ?
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 サルコペニアの定義・診断

P.3 掲載の参考文献
1) Rosenberg IH. Summary comments : Epidemiologic and methodologic problems in determining nutritional status of older persons. Am J Clin Nutr 1989 ; 50 : 1231-3.
 
2) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010 ; 39 : 412-23.
 
3) Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia : consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014 ; 15 : 95-101.
 
4) Manini TM, Clark BC. Dynapenia and aging : an update. J Gerontol A Biol Sci Med Sci 2012 ; 67 : 28-40.
PubMed
5) Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia : an undiagnosed condition in older adults. Current consensus definition : prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011 ; 12 : 249-56.
 
6) McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality : the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci 2014 ; 69 : 576-83.
PubMed
7) Morley JE, Abbatecola AM, Argiles JM, et al. Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility : an international consensus. J Am Med Dir Assoc 2011 ; 12 : 403-9.
PubMed
8) Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia : joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010 ; 29 : 154-9.
PubMed
9) Nishikawa H, Shiraki M, Hiramatsu A, et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1 st edition) : Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 2016 ; 46 : 951-63.
 
10) Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia : revised European consensus on definition and diagnosis. Age Ageing 2019 ; 48 : 16-31.
PubMed
11) Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia : 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020 ; 21 : 300-7.e2.
 
P.5 掲載の参考文献
1) Baek SJ, Nam GE, Han KD, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men : the 2008-2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Invest 2014 ; 37 : 247-60.
 
2) Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004 ; 12 : 1995-2004.
PubMed
3) Han K, Park YM, Kwon HS, et al. Sarcopenia as a determinant of blood pressure in older Koreans : findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS One 2014 ; 9 : e86902.
PubMed
4) Kim TN, Yang SJ, Yoo HJ, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults : the Korean sarcopenic obesity study. Int J Obes (Lond) 2009 ; 33 : 885-92.
PubMed
5) Oh C, Jho S, No JK, et al. Body composition changes were related to nutrient intakes in elderly men but elderly women had a higher prevalence of sarcopenic obesity in a population of Korean adults. Nutr Res 2015 ; 35 : 1-6.
 
6) Ryu M, Jo J, Lee Y, et al. Association of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults : the Fourth Korea National Health and Nutrition Examination Survey. Age Ageing 2013 ; 42 : 734-40.
PubMed
7) Huo YR, Suriyaarachchi P, Gomez F, et al. Phenotype of sarcopenic obesity in older individuals with a history of falling. Arch Gerontol Geriatr 2016 ; 65 : 255-9.
PubMed
8) Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract 2013 ; 7 : e301-7.
PubMed
9) Ishii S, Chang C, Tanaka T, et al. The association between sarcopenic obesity and depressive symptoms in older Japanese adults. PLoS One 2016 ; 11 : e0162898.
PubMed
10) Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts : a population-based study. Lancet Oncol 2008 ; 9 : 629-35.
PubMed
11) Yang YX, Chong MS, Lim WS, et al. Validity of estimating muscle and fat volume from a single MRI section in older adults with sarcopenia and sarcopenic obesity. Clin Radiol 2017 ; 72 : 427.e9-427.e14.
 
12) Tyrovolas S, Koyanagi A, Olaya B, et al. The role of muscle mass and body fat on disability among older adults : A cross-national analysis. Exp Gerontol 2015 ; 69 : 27-35.
PubMed
13) Davison KK, Ford ES, Cogswell ME, et al. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 2002 ; 50 : 1802-9.
 
P.9 掲載の参考文献
1) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010 ; 39 : 412-23.
 
2) Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia : consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014 ; 15 : 95-101.
 
3) Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia : an undiagnosed condition in older adults. Current consensus definition : prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011 ; 12 : 249-56.
 
4) Dam TT, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 2014 ; 69 : 584-90.
PubMed
5) Morley JE, Abbatecola AM, Argiles JM, et al. Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility : an international consensus. J Am Med Dir Assoc 2011 ; 12 : 403-9.
PubMed
6) Nishikawa H, Shiraki M, Hiramatsu A, et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1 st edition) : Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 2016 ; 46 : 951-63.
 
7) Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 2015 ; 16 : 247-52.
PubMed
8) Malmstrom TK, Morley JE. SARC-F : a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013 ; 14 : 531-2.
 
9) Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 2014 ; 14 : 93-101.
PubMed
10) Tanaka T, Takahashi K, Akishita M, et al. "Yubiwakka" (finger-ring) test : a practical self-screening method for sarcopenia, and a predictor of disability and mortality among Japanese community-dwelling older adults. Geriatr Gerontol Int 2017 Sep 12. doi : 10.1111/ggi.13163.
 
11) Watanabe S, Sato K, Hasegawa N, et al. Serum C1q as a novel biomarker of sarcopenia in older adults. FASEB J 2015 ; 29 : 1003-10.
PubMed
12) Drey M, Sieber CC, Bauer JM, et al. FiAT intervention group. C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp Gerontol 2013 ; 48 : 76-80.
 
13) Woo J, Yu R, Tang N, et al. Telomere length is associated with decline in grip strength in older persons aged 65 years and over. Age (Dordr) 2014 ; 36 : 9711.
PubMed
14) Di Renzo L, Gratteri S, Sarlo F, et al. Individually tailored screening of susceptibility to sarcopenia using p 53 codon 72 polymorphism, phenotypes, and conventional risk factors. Dis Markers 2014 ; 2014 : 743634.
 
15) Meng Y, Wu H, Yang Y, et al. Relationship of anabolic and catabolic biomarkers with muscle strength and physical performance in older adults : a population-based cross-sectional study. BMC Musculoskelet Disord 2015 ; 16 : 202.
 
16) Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia : revised European consensus on definition and diagnosis. Age Ageing 2019 ; 48 : 16-31.
PubMed
17) Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia : 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020 ; 21 : 300-7.e2
 

第2章 サルコペニアの疫学

P.13 掲載の参考文献
1) Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults : a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014 ; 43 : 748-59.
PubMed
2) Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia : consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014 ; 15 : 95-101.
 
3) Yoshida D, Suzuki T, Shimada H, et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 2014 ; 14 : 46-51.
PubMed
4) Yoshimura N, Muraki S, Oka H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys, Osteoporos Int 2017 ; 28 : 189-99.
PubMed
5) Lardies-Sanchez B, Sanz-Paris A, Boj-Carceller D, et al. Systematic review : Prevalence of sarcopenia in ageing people using bioelectrical impedance analysis to assess muscle mass. Eur Geriatr Med 2016 ; 7 : 256-61.
 
6) Rubio-Maicas C, Duarte-Alfonso E, Beseler-Soto MR, et al. Prevalence of sarcopenia in a media and long stay Unit. Rev Clin Esp 2014 ; 214 : 303-8.
 
7) Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002 ; 50 : 889-96.
PubMed
8) Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, et al. Sarcopenia in elderly men and women : the Rancho Bernardo study. Am J Prev Med 2003 ; 25 : 226-31.
 
P.15 掲載の参考文献
1) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010 ; 39 : 412-23.
 
2) Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol 2012 ; 24 : 623-7.
PubMed
3) Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia : facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle 2014 ; 5 : 253-9.
PubMed
4) Deitrick JE, Whedon GD, Shorr E. Effects of immobilization upon various metabolic and physiologic functions of normal men. Am J Med 1948 ; 4 : 3-36.
PubMed
5) Volpi E, Sheffield-Moore M, Rasmussen BB, et al. Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA 2001 ; 286 : 1206-12.
 
6) Biolo G, Tipton KD, Klein S, et al. An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol 1997 ; 273 : E 122-9.
 
P.18 掲載の参考文献
1) Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia : The SarcoPhAge study. Exp Gerontol 2015 ; 69 : 103-10.
PubMed
2) Spira D, Buchmann N, Nikolov J, et al. Association of low lean mass with frailty and physical performance : a comparison between two operational definitions of sarcopenia-data from the Berlin Aging Study II (BASE-II). J Gerontol A Biol Sci Med Sci 2015 ; 70 : 779-84.
 
3) Yu R, Leung J, Woo J. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men. J Am Med Dir Assoc 2014 ; 15 : 918-23.
 
4) Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 2015 ; 16 : 247-52.
PubMed
5) Cawthon PM, Blackwell TL, Cauley J, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men : results from the observational osteoporotic fractures in men cohort study. J Am Geriatr Soc 2015 ; 63 : 2247-59.
PubMed
6) Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol Rev 2013 ; 35 : 51-65.
PubMed
7) Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality : a population-based cohort study of older men. J Am Geriatr Soc 2014 ; 62 : 253-60.
 
8) Baek SJ, Nam GE, Han KD, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men : the 2008-2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Invest 2014 ; 37 : 247-60.
 
9) Matsubara Y, Matsumoto T, Aoyagi Y, et al. Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg 2015 ; 61 : 945-50.
PubMed
10) Tolea MI, Galvin JE. Sarcopenia and impairment in cognitive and physical performance. Clin Interv Aging 2015 ; 10 : 663-71.
PubMed
11) Cerri AP, Bellelli G, Mazzone A, et al. Sarcopenia and malnutrition in acutely ill hospitalized elderly : prevalence and outcomes. Clin Nutr 2015 ; 34 : 745-51.
PubMed
12) Du Y, Karvellas CJ, Baracos V, et al. Acute Care and Emergency Surgery (ACES) Group. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 2014 ; 156 : 521-7.
PubMed
13) Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013 ; 100 : 1523-30.
PubMed
14) Iritani S, Imai K, Takai K, et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 2015 ; 50 : 323-32.
PubMed
15) Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013 ; 47 : 861-70.
PubMed
16) Valero V 3 rd, Amini N, Spolverato G, et al. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 2015 ; 19 : 272-81.
 
17) Visser M, van Venrooij LM, Vulperhorst L, et al. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr Metab Cardiovasc Dis 2013 ; 23 : 511-8.
PubMed
18) Lanic H, Kraut-Tauzia J, Modzelewski R, et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 2014 ; 55 : 817-23.
PubMed
19) Villasenor A, Ballard-Barbash R, Baumgartner K, et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors : the HEAL Study. J Cancer Surviv 2012 ; 6 : 398-406.
PubMed
20) Malietzis G, Currie AC, Athanasiou T, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 2016 ; 103 : 572-80.
PubMed
21) Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 2015 ; 261 : 345-52.
PubMed
22) Shachar SS, Williams GR, Muss HB, et al. Prognostic value of sarcopenia in adults with solid tumours : a meta-analysis and systematic review. Eur J Cancer 2016 ; 57 : 58-67.
PubMed
23) Okumura S, Kaido T, Hamaguchi Y, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015 ; 157 : 1088-98.
PubMed
24) Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012 ; 16 : 1478-86.
PubMed
25) Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 2014 ; 9 : 1720-8.
PubMed
P.21 掲載の参考文献
1) Anbalagan VP, Venkataraman V, Pradeepa R, et al. The prevalence of presarcopenia in Asian Indian individuals with and without type 2 diabetes. Diabetes Technol Ther 2013 ; 15 : 768-75.
PubMed
2) Leenders M, Verdijk LB, van der Hoeven L, et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013 ; 14 : 585-92.
PubMed
3) Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia : findings from the National Health and Nutrition Examination Survey III. PLoS One 2010 ; 5 : e10805.
PubMed
4) Ishii S, Tanaka T, Akishita M, et al. Kashiwa study investigators. Metabolic syndrome, sarcopenia and role of sex and age : cross-sectional analysis of Kashiwa cohort study. PLoS One 2014 ; 9 : e112718.
 
5) Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract 2013 ; 7 : e301-7.
PubMed
P.23 掲載の参考文献
1) Jones SE, Maddocks M, Kon SS, et al. Sarcopenia in COPD : prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 2015 ; 70 : 213-8.
PubMed
2) Wasserman P, Segal-Maurer S, Rubin DS. High prevalence of low skeletal muscle mass associated with male gender in midlife and older HIV-infected persons despite CD 4 cell reconstitution and viral suppression. J Int Assoc Provid AIDS Care 2014 ; 13 : 145-52.
 
3) Pinto Neto LF, Sales MC, Scaramussa ES, et al. Human immunodeficiency virus infection and its association with sarcopenia. Braz J Infect Dis 2016 ; 20 : 99-102.
PubMed
4) Harada K, Ida S, Baba Y, et al. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus 2016 ; 29 : 627-33.
PubMed
5) Tamandl D, Paireder M, Asari R, et al. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 2016 ; 26 : 1359-67.
PubMed
6) Tan BH, Brammer K, Randhawa N, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol 2015 ; 41 : 333-8.
PubMed
7) Yip C, Goh V, Davies A, et al. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol 2014 ; 24 : 998-1005.
PubMed
8) Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 2015 ; 22 : 2663-8.
PubMed
9) Thoresen L, Frykholm G, Lydersen S, et al. The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl) 2012 ; 21 : 505-16.
PubMed
10) van Vledder MG, Levolger S, Ayez N, et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012 ; 99 : 550-7.
PubMed
11) Dhooge M, Coriat R, Mir O, et al. Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis. Oncology 2013 ; 84 : 32-8.
 
12) Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 2015 ; 63 : 131-40.
PubMed
13) Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013 ; 100 : 1523-30.
PubMed
14) Iritani S, Imai K, Takai K, et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 2015 ; 50 : 323-32.
PubMed
15) Kamachi S, Mizuta T, Otsuka T, et al. Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepatol Res 2016 ; 46 : 201-8.
PubMed
16) Levolger S, van Vledder MG, Muslem R, et al. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma. J Surg Oncol 2015 ; 112 : 208-13.
PubMed
17) Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol ; 47 : 861-70.
PubMed
18) Mir O, Coriat R, Blanchet B, et al. Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One 2012 ; 7 : e37563.
PubMed
19) Mir O, Coriat R, Boudou-Rouquette P, et al. Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib. Med Oncol 2012 ; 29 : 2793-9.
PubMed
20) Voron T, Tselikas L, Pietrasz D, et al. Sarcopenia impacts on short-and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015 ; 261 : 1173-83.
 
21) Choi Y, Oh DY, Kim TY, et al. Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS One 2015 ; 10 : e0139749.
 
22) Cooper AB, Slack R, Fogelman D, et al. Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Ann Surg Oncol 2015 ; 22 : 2416-23.
PubMed
23) Dalal S, Hui D, Bidaut L, et al. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation : a pilot study. J Pain Symptom Manage 2012 ; 44 : 181-91.
PubMed
24) Tan BH, Birdsell LA, Martin L, et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009 ; 15 : 6973-9.
PubMed
25) Fukushima H, Nakanishi Y, Kataoka M, et al. Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma. J Urol 2016 ; 195 : 26-32.
PubMed
26) Psutka SP, Boorjian SA, Moynagh MR, et al. Decreased skeletal muscle mass is associated with an increased risk of mortality after radical nephrectomy for localized renal cell cancer. J Urol 2016 ; 195 : 270-6.
PubMed
27) Sharma P, Zargar-Shoshtari K, Caracciolo JT, et al. Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Urol Oncol 2015 ; 33 : 339.e17-23.
 
28) Fukushima H, Yokoyama M, Nakanishi Y, et al. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS One 2015 ; 10 : e0115895.
PubMed
29) Psutka SP, Boorjian SA, Moynagh MR, et al. Mortality after radical cystectomy : impact of obesity versus adiposity after adjusting for skeletal muscle wasting. J Urol 2015 ; 193 : 1507-13.
PubMed
30) Stene GB, Helbostad JL, Amundsen T, et al. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol 2015 ; 54 : 340-8.
PubMed
31) Nakamura N, Hara T, Shibata Y, et al. Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Ann Hematol 2015 ; 94 : 2043-53.
PubMed
32) Lanic H, Kraut-Tauzia J, Modzelewski R, et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 2014 ; 55 : 817-23.
PubMed
33) Shachar SS, Williams GR, Muss HB, et al. Prognostic value of sarcopenia in adults with solid tumours : a meta-analysis and systematic review. Eur J Cancer 2016 ; 57 : 58-67.
PubMed
34) Pereira RA, Cordeiro AC, Avesani CM, et al. Sarcopenia in chronic kidney disease on conservative therapy : prevalence and association with mortality. Nephrol Dial Transplant 2015 ; 30 : 1718-25.
PubMed
35) Zhou Y, Hellberg M, Svensson P, et al. Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5. Nephrol Dial Transplant 2017 ; Mar 1. doi : 10.1093/ndt/gfw466
 
36) Moon SJ, Kim TH, Yoon SY, et al. Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011. PLoS One 2015 ; 10 : e0130740.
PubMed
37) Sharma D, Hawkins M, Abramowitz MK. Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. Clin J Am Soc Nephrol 2014 ; 9 : 2079-88.
PubMed
38) Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 2014 ; 9 : 1720-8.
PubMed
39) Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 2014 ; 33 : 64-8.
PubMed
40) Lamarca F, Carrero JJ, Rodrigues JC, et al. Prevalence of sarcopenia in elderly maintenance hemodialysis patients : the impact of different diagnostic criteria. J Nutr Health Aging 2014 ; 18 : 710-7.
 
41) Bataille S, Serveaux M, Carreno E, et al. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr 2017 ; 36 : 1654-60.
PubMed
42) Ren H, Gong D, Jia F, et al. Sarcopenia in patients undergoing maintenance hemodialysis : incidence rate, risk factors and its effect on survival risk. Ren Fail 2016 ; 38 : 364-71.
PubMed
P.27 掲載の参考文献
1) Cederholm T, Cruz-Jentoft AJ, Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 2013 ; 49 : 111-7.
PubMed
2) Waters DL, Hale L, Grant AM, et al. Osteoporosis and gait and balance disturbances in older sarcopenic obese New Zealanders. Osteoporos Int 2010 ; 21 : 351-7.
PubMed
3) Yoshimura N, Muraki S, Oka H, et al. Is osteoporosis a predictor for future sarcopenia, or vice-versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int 2017 ; 28 : 189-99
PubMed
4) Tanimoto Y, Watanabe M, Sun W, et al. Sarcopenia and falls in community-dwelling elderly subjects in Japan : Defining sarcopenia according to criteria of the European Working Group on Sarcopenia in Older People. Arch Gerontol Geriatr 2014 ; 59 : 295-9.
 
5) Oliveira A, Vaz C. The role of sarcopenia in the risk of osteoporotic hip fracture. Clin Rheumatol 2015 ; 34 : 1673-80.
PubMed
6) Verschueren S, Gielen E, O'Neill TW, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int 2013 ; 24 : 87-98.
PubMed
7) Miyakoshi N, Hongo M, Mizutani Y, et al. Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis. J Bone Miner Metab 2013 ; 31 : 556-61.
 
8) Di Monaco M, Castiglioni C, Vallero F, et al. Sarcopenia is more prevalent in men than in women after hip fracture : a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr 2012 ; 55 : e 48-52.
 
9) Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013 ; 13 : 413-20.
PubMed
10) Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 2012 ; 67 : 48-55.
PubMed
11) Yu R, Leung J, Woo J. Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort : results from the Osteoporotic Fractures in Men (MrOs) Study. J Am Med Dir Assoc 2014 ; 15 : 551-8.
 
12) Beenakker KG, Ling CH, Meskers CG, et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 2010 ; 9 : 431-6.
PubMed
P.30 掲載の参考文献
1) Sugimoto T, Ono R, Murata S, et al. Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease. Curr Alzheimer Res 2016 ; 13 : 718-26.
PubMed
2) Papachristou E, Ramsay SE, Lennon LT, et al. The relationships between body composition characteristics and cognitive functioning in a population-based sample of older British men. BMC Geriatr 2015 ; 15 : 172.
 
3) Barichella M, Pinelli G, Iorio L, et al. Sarcopenia and dynapenia in patients with parkinsonism. J Am Med Dir Assoc 2016 ; 17 : 640-6.
PubMed
P.32 掲載の参考文献
1) Kim JS, Wilson JM, Lee SR. Dietary implications on mechanisms of sarcopenia : roles of protein, amino acids and antioxidants. J Nutr Biochem 2010 ; 21 : 1-13.
PubMed
2) Landi F, Marzetti E, Martone AM, et al. Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care 2014 ; 17 : 25-31.
PubMed
3) Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 2015 ; 261 : 345-52.
PubMed
4) Ali S, Garcia JM. Sarcopenia, cachexia and aging : diagnosis, mechanisms and therapeutic options-a mini-review. Gerontology 2014 ; 60 : 294-305
 
5) Cederholm T. Overlaps between frailty and sarcopenia definitions. Nestle Nutr Inst Workshop Ser 2015 ; 83 : 65-9.
PubMed
6) Landi F, Calvani R, Cesari M, et al. Sarcopenia as the biological substrate of physical frailty. Clin Geriatr Med 2015 ; 31 : 367-74.
PubMed
7) Mijnarends DM, Schols JM, Meijers JM, et al. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting : similarities and discrepancies. J Am Med Dir Assoc 2015 ; 16 : 301-8.
 
8) Morley JE, Malmstrom TK. Frailty, sarcopenia, and hormones. Endocrinol Metab Clin North Am 2013 ; 42 : 391-405.
PubMed
9) Spira D, Buchmann N, Nikolov J, et al. Association of low lean mass with frailty and physical performance : a comparison between two operational definitions of sarcopenia-data from the Berlin Aging Study II (BASE-II). J Gerontol A Biol Sci Med Sci 2015 ; 70 : 779-84.
 
10) Carda S, Cisari C, Invernizzi M. Sarcopenia or muscle modifications in neurologic diseases : a lexical or patophysiological difference? Eur J Phys Rehabil Med 2013 ; 49 : 119-30.
 
11) Evans WJ. Skeletal muscle loss : cachexia, sarcopenia, and inactivity. Am J Clin Nutr 2010 ; 91 : 1123S-1127S.
PubMed
12) Ferrucci L, Baroni M, Ranchelli A, et al. Interaction between bone and muscle in older persons with mobility limitations. Curr Pharm Des 2014 ; 20 : 3178-97.
PubMed
13) Phu S, Boersma D, Duque G. Exercise and sarcopenia. J Clin Densitom 2015 ; 18 : 488-92.
PubMed
14) Cerri AP, Bellelli G, Mazzone A, et al. Sarcopenia and malnutrition in acutely ill hospitalized elderly : prevalence and outcomes. Clin Nutr 2015 ; 34 : 745-51.
PubMed
15) Du Y, Karvellas CJ, Baracos V, et al. Acute Care and Emergency Surgery (ACES) Group. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 2014 ; 156 : 521-7.
PubMed

第3章 サルコペニアの予防

P.35 掲載の参考文献
1) 谷本芳美, 渡辺美鈴, 杉浦裕美子, ほか. 地域高齢者におけるサルコペニアに関連する要因の検討. 日本公衛誌 2013 ; 60 : 683-90.
 
2) Isanejad M, Mursu J, Sirola J, et al. Association of protein intake with the change of lean mass among elderly women : The Osteoporosis Risk Factor and Prevention-Fracture Prevention Study (OSTPRE-FPS). J Nutr Sci 2015 ; 4 : e41.
PubMed
3) Welch AA, Kelaiditi E, Jennings A, et al. Dietary magnesium is positively associated with skeletal muscle power and indices of muscle mass and may attenuate the association between circulating c-reactive protein and muscle mass in women. J Bone Miner Res 2016 ; 31 : 317-25.
PubMed
4) Muscariello E, Nasti G, Siervo M, et al. Dietary protein intake in sarcopenic obese older women. Clin Interv Aging 2016 ; 11 : 133-40.
PubMed
P.37 掲載の参考文献
1) 下方浩史, 安藤富士子. 疫学研究からのサルコペニアとそのリスク : 特に栄養との関連. 日老医誌 2012 ; 49 : 721-5.
 
2) Shephard RJ, Park H, Park S, et al. Objectively measured physical activity and progressive loss of lean tissue in older Japanese adults : longitudinal data from the Nakanojo study. J Am Geriatr Soc 2013 ; 61 : 1887-93.
PubMed
3) Yu R, Wong M, Leung J, et al. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int 2014 ; 14 : 15-28.
PubMed
4) Akune T, Muraki S, Oka H, et al. Exercise habits during middle age are associated with lower prevalence of sarcopenia : the ROAD study. Osteoporos Int 2014 ; 25 : 1081-8.
PubMed
5) 山田陽介, 飛奈卓郎, 木村みさか, ほか. 高齢者の筋量と身体活動の強度・量・質の関係を明らかにする : sarcopenia予防のための運動基準作成に向けての基礎的研究. デサントスポーツ科学 2011 ; 32 : 72-80.
 
6) Abe T, Mitsukawa N, Thiebaud RS, et al. Lower body site-specific sarcopenia and accelerometer-determined moderate and vigorous physical activity : the HIREGASAKI study. Aging Clin Exp Res 2012 ; 24 : 657-62.
PubMed
7) 井元淳, 豊永敏宏, 出口純子, ほか. 男性勤労者におけるサルコペニア予備群と身体特性, ライフスタイルとの関係. 日職災医誌 2014 ; 62 : 376-81.
 
8) Park H, Park S, Shephard RJ, et al. Yearlong physical activity and sarcopenia in older adults : the Nakanojo Study. Eur J Appl Physiol 2010 ; 109 : 953-61.
PubMed
9) Kim SH, Kim TH, Hwang HJ. The relationship of physical activity (PA) and walking with sarcopenia in Korean males aged 60 years and older using the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008-2009. Arch Gerontol Geriatr 2013 ; 56 : 472-7.
PubMed
P.39 掲載の参考文献
1) Onder G, Penninx BW, Balkrishnan R, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women : an observational study. Lancet 2002 ; 359 : 926-30.
PubMed
2) Bunout D, Barrera G, de la Maza MP, et al. Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects : a double blind trial. J Renin Angiotensin Aldosterone Syst 2009 ; 10 : 77-84.
 
3) Leenders M, Verdijk LB, van der Hoeven L, et al. Prolonged leucine supplementation does not augment muscle mass or affect glycemic control in elderly type 2 diabetic men. J Nutr 2011 ; 141 : 1070-6.
 
4) Lee CG, Boyko EJ, Barrett-Connor E, et al. Osteoporotic Fractures in Men (MrOS) Study Research Group. Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care 2011 ; 34 : 2381-6.
 
5) Rizzo MR, Barbieri M, Fava I, et al. Sarcopenia in elderly diabetic patients : role of dipeptidyl peptidase 4 inhibitors. J Am Med Dir Assoc 2016 ; 17 : 896-901.
PubMed
6) Castaneda C, Gordon PL, Uhlin KL, et al. Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. Ann Intern Med 2001 ; 135 : 965-76.
PubMed
7) Heiwe S, Jacobson SH. Exercise training in adults with CKD : a systematic review and meta-analysis. Am J Kidney Dis 2014 ; 64 : 383-93.
PubMed
8) Martin-Alemany G, Valdez-Ortiz R, Olvera-Soto G, et al. The effects of resistance exercise and oral nutritional supplementation during hemodialysis on indicators of nutritional status and quality of life. Nephrol Dial Transplant 2016 ; 31 : 1712-20.
PubMed
9) Pineda-Juarez JA, Sanchez-Ortiz NA, Castillo-Martinez L, et al. Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation. Clin Nutr 2016 ; 35 : 41-7.
PubMed
10) Tsien C, Davuluri G, Singh D, et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis. Hepatology 2015 ; 61 : 2018-29.
PubMed
11) Yamanaka-Okumura H, Nakamura T, Miyake H, et al. Effect of long-term late-evening snack on health-related quality of life in cirrhotic patients. Hepatol Res 2010 ; 40 : 470-6.
PubMed
12) Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, et al. Androgen treatment and muscle strength in elderly men : a meta-analysis. J Am Geriatr Soc 2006 ; 54 : 1666-73.
 

第4章 サルコペニアの治療

P.48 掲載の参考文献
1) Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults : a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014 ; 43 : 748-59.
PubMed
2) Binder EF, Yarasheski KE, Steger-May K, et al. Effects of progressive resistance training on body composition in frail older adults : results of a randomized, controlled trial. J Gerontol A Biol Sci Med Sci 2005 ; 60 : 1425-31.
PubMed
3) Bunout D, Barrera G, de la Maza P, et al. The impact of nutritional supplementation and resistance training on the health functioning of free-living Chilean elders : results of 18 months of follow-up. J Nutr 2001 ; 131 : 2441S-6S.
PubMed
4) Suetta C, Andersen JL, Dalgas U, et al. Resistance training induces qualitative changes in muscle morphology, muscle architecture, and muscle function in elderly postoperative patients. J Appl Physiol 2008 ; 105 : 180-6.
PubMed
5) Kemmler W, von Stengel S, Engelke K, et al. Exercise, body composition, and functional ability : a randomized controlled trial. Am J Prev Med 2010 ; 38 : 279-87.
PubMed
6) Rydwik E, Lammes E, Frandin K, et al. Effects of a physical and nutritional intervention program for frail elderly people over age 75 : a randomized controlled pilot treatment trial. Aging Clin Exp Res 2008 ; 20 : 159-70.
PubMed
7) Bonnefoy M, Cornu C, Normand S, et al. The effects of exercise and protein-energy supplements on body composition and muscle function in frail elderly individuals : a long-term controlled randomised study. Br J Nutr 2003 ; 89 : 731-9.
PubMed
8) Yoshimura Y, Wakabayashi H, Yamada M, et al. Interventions for treating sarcopenia : a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc 2017 ; 18 : 553.e1-553.e16.
 
9) Kim HK, Suzuki T, Saito K, et al. Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women : a randomized controlled trial. J Am Geriatr Soc 2012 ; 60 : 16-23.
PubMed
10) Kim H, Suzuki T, Saito K, et al. Effects of exercise and tea catechins on muscle mass, strength and walking ability in community-dwelling elderly Japanese sarcopenic women : a randomized controlled trial. Geriatr Gerontol Int 2013 ; 13 : 458-65.
PubMed
11) Kim H, Kim M, Kojima N, et al. Exercise and nutritional supplementation on community-dwelling elderly Japanese women with sarcopenic obesity : a randomized controlled trial. J Am Med Dir Assoc 2016 ; 17 : 1011-9.
PubMed
12) Wei N, Pang MY, Ng SS, et al. Optimal frequency/time combination of whole-body vibration training for improving muscle size and strength of people with age-related muscle loss (sarcopenia) : a randomized controlled trial. Geriatr Gerontol Int 2016 Aug 31. doi : 10.1111/ggi.12878.
 
P.53 掲載の参考文献
1) Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults : a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS), Age Ageing 2014 ; 43 : 748-59.
PubMed
2) Tieland M, van de Rest O, Dirks ML, et al. Protein supplementation improves physical performance in frail elderly people : a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012 ; 13 : 720-6.
 
3) Kim HK, Suzuki T, Saito K, et al. Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women : a randomized controlled trial. J Am Geriatr Soc 2012 ; 60 : 16-23.
PubMed
4) Kim H, Suzuki T, Saito K, et al. Effects of exercise and tea catechins on muscle mass, strength and walking ability in community-dwelling elderly Japanese sarcopenic women : a randomized controlled trial. Geriatr Gerontol Int 2013 ; 13 : 458-65.
PubMed
5) Flakoll P, Sharp R, Baier S, et al. Effect of betahydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition 2004 ; 20 : 445-51.
 
6) Tieland M, Dirks ML, van der Zwaluw N, et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people : a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012 ; 13 : 713-9.
 
7) Yoshimura Y, Wakabayashi H, Yamada M, et al. Interventions for treating sarcopenia : a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc 2017 ; 18 : 553.e1-553.e16.
 
8) Kim H, Kim M, Kojima N, et al. Exercise and nutritional supplementation on community-dwelling elderly Japanese women with sarcopenic obesity : a randomized controlled trial. J Am Med Dir Assoc 2016 ; 17 : 1011-9.
PubMed
9) Maltais ML, Ladouceur JP, Dionne IJ. The effect of resistance training and different sources of postexercise protein supplementation on muscle mass and physical capacity in sarcopenic elderly men. J Strength Cond Res 2016 ; 30 : 1680-7.
 
10) Bonnefoy M, Cornu C, Normand S, et al. The effects of exercise and protein-energy supplements on body composition and muscle function in frail elderly individuals : a long-term controlled randomised study. Br J Nutr 2003 ; 89 : 731-9.
PubMed
11) Zdzieblik D, Oesser S, Baumstark MW, et al. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men : a randomised controlled trial. Br J Nutr 2015 ; 114 : 1237-45.
 
P.57 掲載の参考文献
1) Dobs AS, Nguyen T, Pace C, et al. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 2002 ; 87 : 1509-16.
PubMed
2) Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004 ; 89 : 2085-98.
 
3) Bhasin S, Jasuja R. Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care 2009 ; 12 : 232-40.
PubMed
4) Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women : results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2011 ; 2 : 153-61.
PubMed
5) Yoshimura Y, Wakabayashi H, Yamada M, et al. Interventions for treating sarcopenia : a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc 2017 ; 18 : 553.e1-553.e16.
 
6) Papanicolaou DA, Ather SN, Zhu H, et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM). MK-0773 in female participants with sarcopenia. J Nutr Health Aging 2013 ; 17 : 533-43.
 
P.62 掲載の参考文献
1) Yoshimura Y, Wakabayashi H, Yamada M, et al. Interventions for treating sarcopenia : a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc 2017 ; 18 : 553.e1-553.e16.
 
2) Kim HK, Suzuki T, Saito K, et al. Effects of exercise and amino acid supplementation on body composition and physical function in communityd-welling elderly Japanese sarcopenic women : a randomized controlled trial. J Am Geriatr Soc 2012 ; 60 : 16-23.
 
3) Kim H, Suzuki T, Saito K, et al. Effects of exercise and tea catechins on muscle mass, strength and walking ability in community-dwelling elderly Japanese sarcopenic women : a randomized controlled trial. Geriatr Gerontol Int 2013 ; 13 : 458-65.
PubMed
4) Kim H, Kim M, Kojima N, et al. Exercise and nutritional supplementation on community-dwelling elderly Japanese women with sarcopenic obesity : a randomized controlled trial. J Am Med Dir Assoc 2016 ; 17 : 1011-9.
PubMed
5) Zdzieblik D, Oesser S, Baumstark MW, et al. with resistance training improves body composition and increases muscle strength in elderly sarcopenic men : a randomised controlled trial. Br J Nutr 2015 ; 114 : 1237-45.
 
6) Rondanelli M, Klersy C, Terracol G, et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr 2016 ; 103 : 830-40.
PubMed
7) Sugawara K, Takahashi H, Kasai C, et al. Effects of nutritional supplementation combined with lowintensity exercise in malnourished patients with COPD. Respir Med 2010 ; 104 : 1883-9.
PubMed
8) Rydwik E, Lammes E, Frandin K, et al. Effects of a physical and nutritional intervention program for frail elderly people over age 75 : a randomized controlled pilot treatment trial. Aging Clin Exp Res 2008 ; 20 : 159-70.
PubMed
9) Swanenburg J, de Bruin ED, Stauffacher M, et al. Effects of exercise and nutrition on postural balance and risk of falling in elderly people with decreased bone mineral density : randomized controlled trial pilot study. Clin Rehabil 2007 ; 21 : 523-34.
PubMed
P.65 掲載の参考文献
1) Mochamat H, Cuhls M, Marinova S, et al. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer : a European Palliative Care Research Centre cachexia project. J Cachexia Sarcopenia Muscle 2017 ; 8 : 25-39.
 
2) Hojan K, Milecki P, Molinska-Glura M, et al. Effect of physical activity on bone strength and body composition in breast cancer premenopausal women during endocrine therapy. Eur J Phys Rehabil Med 2013 ; 49 : 331-9.
 
3) Galvao DA, Taaffe DR, Spry N, et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases : a randomized controlled trial. J Clin Oncol 2010 ; 28 : 340-7.
PubMed
4) Dal Negro RW, Aquilani R, Bertacco S, et al. Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia. Monaldi Arch Chest Dis 2010 ; 73 : 25-33.
PubMed
5) Moon SJ, Kim TH, Yoon SY, et al. Relationship between Stage of Chronic Kidney Disease and Sarcopenia in Korean Aged 40 Years and Older Using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2). 2008-2011. PLoS One 2015 ; 10 : e0130740.
PubMed
6) Hirai K, Ookawara S, Morishita Y. Sarcopenia and physical inactivity in patients with chronic kidney disease. Nephrourol Mon 2016 ; 8 : e37443.
PubMed
7) Rossi AP, Burris DD, Lucas FL, et al. Effects of a renal rehabilitation exercise program in patients with CKD : a randomized, controlled trial. Clin J Am Soc Nephrol 2014 ; 9 : 2052-8.
PubMed
8) Fulster S, Tacke M, Sandek A, et al. Muscle wasting in patients with chronic heart failure : results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 2013 ; 34 : 512-9.
PubMed
9) Collamati A, Marzetti E, Calvani R, et al. Sarcopenia in heart failure : mechanisms and therapeutic strategies. J Geriatr Cardiol 2016 ; 13 : 615-24.
PubMed
10) Rozentryt P, von Haehling S, Lainscak M, et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers : a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle 2010 ; 1 : 35-42.
PubMed
11) Lenk K, Erbs S, Hollriegel R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol 2012 ; 19 : 404-11.
 
12) Cunha TF, Bacurau AV, Moreira JB, et al. Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLoS One 2012 ; 7 : e41701.
PubMed
13) Caminiti G, Volterrani M, Iellamo F, et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009 ; 54 : 919-27.
PubMed
14) Kenny AM, Kleppinger A, Annis K, et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc 2010 ; 58 : 1134-43.
 
15) Park JH, Park KH, Cho S, et al. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women. Menopause 2013 ; 20 : 747-53.
PubMed

書評

最近チェックした商品履歴

Loading...